Sandu Pharma Appoints Dave & Dave as Statutory Auditors

Sandu Pharmaceuticals Ltd announced the appointment of M/s Dave & Dave Chartered Accountants as its statutory auditor for a five-year term, subject to shareholder approval. The Board of Directors, based on the Audit Committee's recommendation, approved the appointment. The firm, established in 1989, has extensive experience and is not related to any company directors or key personnel. The company also approved its unaudited standalone financial results for the quarter ended June 30, 2026, along with various reports for the financial year ended March 31, 2026. The 41st Annual General Meeting is scheduled for September 11, 2026, and a record date of September 4, 2026, has been set for dividend eligibility.